Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6 (2003)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1038/sj.tpj.6500160
- Subjects: FARMACOLOGIA CLÍNICA; FARMACOLOGIA MÉDICA; FARMACODINÂMICA
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 3, n. 2, p. 105-113, 2003
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DESAI, M. et al. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. The Pharmacogenomics Journal, v. 3, n. 2, p. 105-113, 2003Tradução . . Disponível em: https://doi.org/10.1038/sj.tpj.6500160. Acesso em: 30 out. 2024. -
APA
Desai, M., Tanus-Santos, J. E., Li, L., Gorski, J. C., Arefayene, M., Liu, Y., et al. (2003). Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. The Pharmacogenomics Journal, 3( 2), 105-113. doi:10.1038/sj.tpj.6500160 -
NLM
Desai M, Tanus-Santos JE, Li L, Gorski JC, Arefayene M, Liu Y, Desta Z, Flockhart DA. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6 [Internet]. The Pharmacogenomics Journal. 2003 ; 3( 2): 105-113.[citado 2024 out. 30 ] Available from: https://doi.org/10.1038/sj.tpj.6500160 -
Vancouver
Desai M, Tanus-Santos JE, Li L, Gorski JC, Arefayene M, Liu Y, Desta Z, Flockhart DA. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6 [Internet]. The Pharmacogenomics Journal. 2003 ; 3( 2): 105-113.[citado 2024 out. 30 ] Available from: https://doi.org/10.1038/sj.tpj.6500160 - Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
- Estudo de associação de haplótipos da Enos e insuficiência renal crônica
Informações sobre o DOI: 10.1038/sj.tpj.6500160 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
